Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a basic helix-loop-helix-leucine zipper (bHLH-Zip) transcription factor that binds to the sterol regulatory element-1 (SRE1), which is a motif that is found in the promoter of the low density lipoprotein receptor gene and other genes involved in sterol biosynthesis. The encoded protein is synthesized as a precursor that is initially attached to the nuclear membrane and endoplasmic reticulum. Following cleavage, the mature protein translocates to the nucleus and activates transcription. This cleaveage is inhibited by sterols. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Alternative promoter usage and splicing result in multiple transcript variants, including SREBP-1a and SREBP-1c, which correspond to RefSeq transcript variants 2 and 3, respectively. [provided by RefSeq, Nov 2017]
SREBF1 (Sterol Regulatory Element Binding Transcription Factor 1) is a Protein Coding gene. Diseases associated with SREBF1 include Ifap Syndrome 2 and Mucoepithelial Dysplasia, Hereditary. Among its related pathways are BMAL1-CLOCK,NPAS2 activates circadian gene expression and Apoptosis and survival Caspase cascade. Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and chromatin binding. An important paralog of this gene is SREBF2.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | IDA | 23610160 |
GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding | IBA | 21873635 |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | ISA | -- |
GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | IEA | -- |
GO:0003677 | DNA binding | ISS | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000139 | Golgi membrane | TAS | -- |
GO:0000785 | chromatin | ISA | -- |
GO:0005634 | nucleus | TAS,IDA | 15358760 |
GO:0005635 | nuclear envelope | TAS | 8156598 |
GO:0005654 | nucleoplasm | TAS | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | IEA | -- |
GO:0003062 | regulation of heart rate by chemical signal | IEA | -- |
GO:0006355 | regulation of transcription, DNA-templated | IEA | -- |
GO:0006357 | regulation of transcription by RNA polymerase II | TAS,IBA | 21873635 |
GO:0006629 | lipid metabolic process | TAS | 8156598 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Docosahexaenoic acid | Approved, Investigational | Pharma | Target, inhibitor | 0 | ||
Omega-3-acid ethyl esters | Approved, Investigational | Pharma | Target, inhibitor | 0 | ||
Fish oil | Approved | Nutra | Target, regulator | 0 | ||
Omega-3 fatty acids | Approved | Nutra | Target, inhibitor | 0 | ||
Fluvastatin | Approved | Pharma | HMGCR inhibitor | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs |
---|
ExUns: | 1 | ^ | 2a | · | 2b | ^ | 3a | · | 3b | · | 3c | · | 3d | · | 3e | ^ | 4 | ^ | 5a | · | 5b | · | 5c | ^ | 6a | · | 6b | ^ | 7a | · | 7b | · | 7c | ^ | 8a | · | 8b | ^ | 9a | · | 9b | · | 9c | · | 9d | ^ | 10a | · | 10b | ^ | 11 | ^ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | |||||||||||||||||||||||||||||||||||||||||||||||||||
SP2: | - | |||||||||||||||||||||||||||||||||||||||||||||||||||
SP3: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP4: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP5: | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||
SP6: | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
SP7: | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||
SP8: | - | - | ||||||||||||||||||||||||||||||||||||||||||||||||||
SP9: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP10: | - | |||||||||||||||||||||||||||||||||||||||||||||||||||
SP11: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP12: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP13: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP14: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP15: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP16: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP17: | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||
SP18: | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP19: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP20: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP21: | - | - |
ExUns: | 12a | · | 12b | ^ | 13a | · | 13b | · | 13c | · | 13d | ^ | 14 | ^ | 15a | · | 15b | ^ | 16 | ^ | 17a | · | 17b | · | 17c | · | 17d | ^ | 18a | · | 18b | · | 18c | · | 18d | ^ | 19 | ^ | 20a | · | 20b | ^ | 21 | ^ | 22a | · | 22b | ^ | 23 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP2: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP3: | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
SP4: | - | ||||||||||||||||||||||||||||||||||||||||||||||||
SP5: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP6: | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||
SP7: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP8: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP9: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP10: | - | ||||||||||||||||||||||||||||||||||||||||||||||||
SP11: | - | ||||||||||||||||||||||||||||||||||||||||||||||||
SP12: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP13: | - | ||||||||||||||||||||||||||||||||||||||||||||||||
SP14: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP15: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP16: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP17: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP18: | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||
SP19: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP20: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP21: |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | SREBF1 30 |
|
||
Dog (Canis familiaris) |
Mammalia | SREBF1 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | SREBF1 30 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Srebf1 30 |
|
||
Mouse (Mus musculus) |
Mammalia | Srebf1 30 17 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | SREBF1 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | SREBF1 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | SREBF1 30 |
|
||
SREBP-1 31 |
|
OneToOne | |||
Lizard (Anolis carolinensis) |
Reptilia | SREBF1 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | srebf1 30 |
|
||
African clawed frog (Xenopus laevis) |
Amphibia | Xl.12057 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | srebf1 30 31 |
|
OneToOne | |
African malaria mosquito (Anopheles gambiae) |
Insecta | AgaP_AGAP000076 30 |
|
||
Fruit Fly (Drosophila melanogaster) |
Insecta | HLH106 30 31 32 |
|
OneToMany | |
Worm (Caenorhabditis elegans) |
Secernentea | sbp-1 31 |
|
OneToMany | |
Sea Squirt (Ciona savignyi) |
Ascidiacea | CSA.9273 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 17 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
932243 | Pathogenic: IFAP syndrome with or without BRESHECK syndrome; Hereditary mucoepithelial dysplasia; IFAP syndrome 2 | 17,817,283(-) |
G/A NM_001005291.3(SREBF1):c.1669C>T (p.Arg557Cys) |
MISSENSE | |
932244 | Pathogenic: IFAP syndrome with or without BRESHECK syndrome; IFAP syndrome 2 | 17,817,277(-) |
CGTT/C NM_001005291.3(SREBF1):c.1672_1674del (p.Asn558del) |
INFRAME_DELETION | |
932245 | Pathogenic: IFAP syndrome with or without BRESHECK syndrome; IFAP syndrome 2 | 17,817,273(-) |
A/G NM_001005291.3(SREBF1):c.1679T>C (p.Leu560Pro) |
MISSENSE | |
981495 | Pathogenic: Hereditary mucoepithelial dysplasia | 17,817,282(-) |
C/T NM_004176.5(SREBF1):c.1580G>A (p.Arg527His) |
MISSENSE | |
rs114001633 | Likely Benign: not provided | 17,819,659(-) |
G/A NM_001005291.3(SREBF1):c.680C>T (p.Pro227Leu) |
MISSENSE |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv2659754 | CNV | deletion | 23128226 |
nsv1120111 | OTHER | inversion | 24896259 |
nsv155 | OTHER | inversion | 15895083 |
nsv499114 | OTHER | inversion | 21111241 |
nsv513466 | CNV | insertion | 21212237 |
nsv522668 | CNV | loss | 19592680 |
nsv526904 | CNV | loss | 19592680 |
nsv817753 | CNV | loss | 17921354 |
nsv820244 | CNV | loss | 19587683 |
nsv833385 | CNV | loss | 17160897 |
nsv953838 | CNV | deletion | 24416366 |
Disorder | Aliases | PubMed IDs |
---|---|---|
ifap syndrome 2 |
|
|
mucoepithelial dysplasia, hereditary |
|
|
ifap syndrome 1, with or without bresheck syndrome |
|
|
ichthyosis follicularis atrichia photophobia syndrome |
|
|
fatty liver disease |
|
|